Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Seminars in Liver Disease
|
May 5, 2006
Current issues and future directions in treatment
Chee-Kin Hui, George K K Lau
Expert Review of Anti-Infective Therapy
|
August 19, 2005
Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B
Chee-Kin Hui, George K K Lau
Expert Opinion on Investigational Drugs
|
September 28, 2005
Clevudine for the treatment of chronic hepatitis B virus infection
Chee-Kin Hui, George K K Lau
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 8, 2006
Immune system and hepatitis B virus infection
Chee-Kin Hui, George K K Lau
Journal of Hepatology
|
March 29, 2003
A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase
Chee-Kin Hui, Tigist Belaye, Kevin Montegrande, et al.
International Journal of Nanomedicine
|
August 28, 2007
Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
Lawrence Lai, Chee-Kin Hui, Nancy Leung, et al.
Gastroenterology Clinics of North America
|
August 25, 2004
Management of chronic hepatitis B in treatment-experienced patients
Chee-Kin Hui, Hai-ying Zhang, George K K Lau
Journal of Clinical Gastroenterology
|
August 23, 2002
Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinoma
Man-Fung Yuen, Charmaine Hon, Chee-Kin Hui, et al.
Cancer
|
March 29, 2002
A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
Annie O Chan, Man-Fung Yuen, Chee-Kin Hui, et al.
Journal of Clinical Gastroenterology
|
August 23, 2002
Mirtazapine-induced hepatotoxicity
Chee-Kin Hui, Man-Fung Yuen, Wai-Man Wong, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Seminars in Liver Disease
|
May 5, 2006
Current issues and future directions in treatment
Chee-Kin Hui, George K K Lau
Expert Review of Anti-Infective Therapy
|
August 19, 2005
Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B
Chee-Kin Hui, George K K Lau
Expert Opinion on Investigational Drugs
|
September 28, 2005
Clevudine for the treatment of chronic hepatitis B virus infection
Chee-Kin Hui, George K K Lau
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 8, 2006
Immune system and hepatitis B virus infection
Chee-Kin Hui, George K K Lau
Journal of Hepatology
|
March 29, 2003
A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase
Chee-Kin Hui, Tigist Belaye, Kevin Montegrande, et al.
International Journal of Nanomedicine
|
August 28, 2007
Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
Lawrence Lai, Chee-Kin Hui, Nancy Leung, et al.
Gastroenterology Clinics of North America
|
August 25, 2004
Management of chronic hepatitis B in treatment-experienced patients
Chee-Kin Hui, Hai-ying Zhang, George K K Lau
Journal of Clinical Gastroenterology
|
August 23, 2002
Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinoma
Man-Fung Yuen, Charmaine Hon, Chee-Kin Hui, et al.
Cancer
|
March 29, 2002
A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
Annie O Chan, Man-Fung Yuen, Chee-Kin Hui, et al.
Journal of Clinical Gastroenterology
|
August 23, 2002
Mirtazapine-induced hepatotoxicity
Chee-Kin Hui, Man-Fung Yuen, Wai-Man Wong, et al.
Page
of 6